Quantitative expression of HLA class I molecules in acute non-lymphoblastic leukaemia cells

The present study concerns a panel of 33 acute non lymphoblastic leukaemia (ANLL) patients, previously typed for HLA-A,B serological specificities and including samples with a normal HLA-A,B phenotype (3,4 detected specificities) as well as samples with missing and extra specificities. Samples were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of immunogenetics 1993-06, Vol.20 (3), p.165-173
Hauptverfasser: D'ALFONSO, S, SAVOIA, P, PITTI, G, PERUCCIO, D, POZZI, C, CREPALDI, T, FALDA, M, FICARA, F, RESEGOTTI, L, MOMIGLIANO RICHIARDI, P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 173
container_issue 3
container_start_page 165
container_title European journal of immunogenetics
container_volume 20
creator D'ALFONSO, S
SAVOIA, P
PITTI, G
PERUCCIO, D
POZZI, C
CREPALDI, T
FALDA, M
FICARA, F
RESEGOTTI, L
MOMIGLIANO RICHIARDI, P
description The present study concerns a panel of 33 acute non lymphoblastic leukaemia (ANLL) patients, previously typed for HLA-A,B serological specificities and including samples with a normal HLA-A,B phenotype (3,4 detected specificities) as well as samples with missing and extra specificities. Samples were analysed at the protein and/or RNA level in order to verify whether the observed typing anomalies were due to a modified quantitative expression of class I molecules. The number of HLA-A,B assigned specificities correlated significantly with the cell surface class I expression detected by indirect immunofluorescence using the monomorphic anti-class I MoAb W6/32 (Spearman rank correlation test, P < 0.01) and with the amount of class I Heavy Chain (HC, P < 0.05) and beta-2-microglobulin (beta 2m, P < 0.05) evaluated by Western blot in whole cell extracts. The RNA analysis suggested a HC-beta 2m coordinated down regulation at the mRNA level in a patient with no assigned HLA-A,B specificities. Another patient with no detectable HLA-A,B specificities showed a low expression selectively of the beta 2m protein. The results reported here demonstrate a heterogenous quantitative HLA class I expression in ANLL blasts, analogous to results reported for solid tumours.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_75858855</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75858855</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1134-84e08cc71d8ae0fb455f47a906e132be428b71d18a3134744de914f4a0aede2d3</originalsourceid><addsrcrecordid>eNqF0M1KxDAUBeAgyjiOPoKQhbgrJE3SJsthUGdgQARduSi36S1G0x-bRpy3n4rFrau7OB-Hwz0hSy4ylaQiZ6dkyUzGklym7JxchPDOGBfcZAuy0EJozeWSvD5FaEc3wui-kOJ3P2AIrmtpV9Ptfk2thxDojjadRxs9BupaCjaOSNuuTfyh6d-6ckKjs9Rj_ABsHFCL3odLclaDD3g13xV5ub973myT_ePDbrPeJz3nQiZaItPW5rzSgKwupVK1zMGwDLlIS5SpLqeQaxATz6Ws0HBZS2CAFaaVWJHb395-6D4jhrFoXPhZAC12MRS50kprpf6FPMuM0YpP8HqGsWywKvrBNTAcivltU34z5xAs-HqA1rrwx6RJzTRfHAFHUnb9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16699851</pqid></control><display><type>article</type><title>Quantitative expression of HLA class I molecules in acute non-lymphoblastic leukaemia cells</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>D'ALFONSO, S ; SAVOIA, P ; PITTI, G ; PERUCCIO, D ; POZZI, C ; CREPALDI, T ; FALDA, M ; FICARA, F ; RESEGOTTI, L ; MOMIGLIANO RICHIARDI, P</creator><creatorcontrib>D'ALFONSO, S ; SAVOIA, P ; PITTI, G ; PERUCCIO, D ; POZZI, C ; CREPALDI, T ; FALDA, M ; FICARA, F ; RESEGOTTI, L ; MOMIGLIANO RICHIARDI, P</creatorcontrib><description>The present study concerns a panel of 33 acute non lymphoblastic leukaemia (ANLL) patients, previously typed for HLA-A,B serological specificities and including samples with a normal HLA-A,B phenotype (3,4 detected specificities) as well as samples with missing and extra specificities. Samples were analysed at the protein and/or RNA level in order to verify whether the observed typing anomalies were due to a modified quantitative expression of class I molecules. The number of HLA-A,B assigned specificities correlated significantly with the cell surface class I expression detected by indirect immunofluorescence using the monomorphic anti-class I MoAb W6/32 (Spearman rank correlation test, P &lt; 0.01) and with the amount of class I Heavy Chain (HC, P &lt; 0.05) and beta-2-microglobulin (beta 2m, P &lt; 0.05) evaluated by Western blot in whole cell extracts. The RNA analysis suggested a HC-beta 2m coordinated down regulation at the mRNA level in a patient with no assigned HLA-A,B specificities. Another patient with no detectable HLA-A,B specificities showed a low expression selectively of the beta 2m protein. The results reported here demonstrate a heterogenous quantitative HLA class I expression in ANLL blasts, analogous to results reported for solid tumours.</description><identifier>ISSN: 0960-7420</identifier><identifier>EISSN: 1365-2370</identifier><identifier>PMID: 8338814</identifier><language>eng</language><publisher>Oxford: Blackwell</publisher><subject>Antigens, Neoplasm - biosynthesis ; Antigens, Neoplasm - genetics ; beta 2-Microglobulin - biosynthesis ; beta 2-Microglobulin - genetics ; Biological and medical sciences ; Gene Expression Regulation, Leukemic ; Hematologic and hematopoietic diseases ; HLA-A Antigens - biosynthesis ; HLA-A Antigens - genetics ; HLA-B Antigens - biosynthesis ; HLA-B Antigens - genetics ; Humans ; Leukemia, Myeloid, Acute - genetics ; Leukemia, Myeloid, Acute - immunology ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Medical sciences ; Neoplasm Proteins - biosynthesis ; Neoplasm Proteins - genetics ; Neoplastic Stem Cells - immunology ; Neoplastic Stem Cells - metabolism ; RNA, Messenger - genetics ; RNA, Neoplasm - genetics</subject><ispartof>European journal of immunogenetics, 1993-06, Vol.20 (3), p.165-173</ispartof><rights>1993 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4929906$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8338814$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>D'ALFONSO, S</creatorcontrib><creatorcontrib>SAVOIA, P</creatorcontrib><creatorcontrib>PITTI, G</creatorcontrib><creatorcontrib>PERUCCIO, D</creatorcontrib><creatorcontrib>POZZI, C</creatorcontrib><creatorcontrib>CREPALDI, T</creatorcontrib><creatorcontrib>FALDA, M</creatorcontrib><creatorcontrib>FICARA, F</creatorcontrib><creatorcontrib>RESEGOTTI, L</creatorcontrib><creatorcontrib>MOMIGLIANO RICHIARDI, P</creatorcontrib><title>Quantitative expression of HLA class I molecules in acute non-lymphoblastic leukaemia cells</title><title>European journal of immunogenetics</title><addtitle>Eur J Immunogenet</addtitle><description>The present study concerns a panel of 33 acute non lymphoblastic leukaemia (ANLL) patients, previously typed for HLA-A,B serological specificities and including samples with a normal HLA-A,B phenotype (3,4 detected specificities) as well as samples with missing and extra specificities. Samples were analysed at the protein and/or RNA level in order to verify whether the observed typing anomalies were due to a modified quantitative expression of class I molecules. The number of HLA-A,B assigned specificities correlated significantly with the cell surface class I expression detected by indirect immunofluorescence using the monomorphic anti-class I MoAb W6/32 (Spearman rank correlation test, P &lt; 0.01) and with the amount of class I Heavy Chain (HC, P &lt; 0.05) and beta-2-microglobulin (beta 2m, P &lt; 0.05) evaluated by Western blot in whole cell extracts. The RNA analysis suggested a HC-beta 2m coordinated down regulation at the mRNA level in a patient with no assigned HLA-A,B specificities. Another patient with no detectable HLA-A,B specificities showed a low expression selectively of the beta 2m protein. The results reported here demonstrate a heterogenous quantitative HLA class I expression in ANLL blasts, analogous to results reported for solid tumours.</description><subject>Antigens, Neoplasm - biosynthesis</subject><subject>Antigens, Neoplasm - genetics</subject><subject>beta 2-Microglobulin - biosynthesis</subject><subject>beta 2-Microglobulin - genetics</subject><subject>Biological and medical sciences</subject><subject>Gene Expression Regulation, Leukemic</subject><subject>Hematologic and hematopoietic diseases</subject><subject>HLA-A Antigens - biosynthesis</subject><subject>HLA-A Antigens - genetics</subject><subject>HLA-B Antigens - biosynthesis</subject><subject>HLA-B Antigens - genetics</subject><subject>Humans</subject><subject>Leukemia, Myeloid, Acute - genetics</subject><subject>Leukemia, Myeloid, Acute - immunology</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Medical sciences</subject><subject>Neoplasm Proteins - biosynthesis</subject><subject>Neoplasm Proteins - genetics</subject><subject>Neoplastic Stem Cells - immunology</subject><subject>Neoplastic Stem Cells - metabolism</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Neoplasm - genetics</subject><issn>0960-7420</issn><issn>1365-2370</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0M1KxDAUBeAgyjiOPoKQhbgrJE3SJsthUGdgQARduSi36S1G0x-bRpy3n4rFrau7OB-Hwz0hSy4ylaQiZ6dkyUzGklym7JxchPDOGBfcZAuy0EJozeWSvD5FaEc3wui-kOJ3P2AIrmtpV9Ptfk2thxDojjadRxs9BupaCjaOSNuuTfyh6d-6ckKjs9Rj_ABsHFCL3odLclaDD3g13xV5ub973myT_ePDbrPeJz3nQiZaItPW5rzSgKwupVK1zMGwDLlIS5SpLqeQaxATz6Ws0HBZS2CAFaaVWJHb395-6D4jhrFoXPhZAC12MRS50kprpf6FPMuM0YpP8HqGsWywKvrBNTAcivltU34z5xAs-HqA1rrwx6RJzTRfHAFHUnb9</recordid><startdate>199306</startdate><enddate>199306</enddate><creator>D'ALFONSO, S</creator><creator>SAVOIA, P</creator><creator>PITTI, G</creator><creator>PERUCCIO, D</creator><creator>POZZI, C</creator><creator>CREPALDI, T</creator><creator>FALDA, M</creator><creator>FICARA, F</creator><creator>RESEGOTTI, L</creator><creator>MOMIGLIANO RICHIARDI, P</creator><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>199306</creationdate><title>Quantitative expression of HLA class I molecules in acute non-lymphoblastic leukaemia cells</title><author>D'ALFONSO, S ; SAVOIA, P ; PITTI, G ; PERUCCIO, D ; POZZI, C ; CREPALDI, T ; FALDA, M ; FICARA, F ; RESEGOTTI, L ; MOMIGLIANO RICHIARDI, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1134-84e08cc71d8ae0fb455f47a906e132be428b71d18a3134744de914f4a0aede2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Antigens, Neoplasm - biosynthesis</topic><topic>Antigens, Neoplasm - genetics</topic><topic>beta 2-Microglobulin - biosynthesis</topic><topic>beta 2-Microglobulin - genetics</topic><topic>Biological and medical sciences</topic><topic>Gene Expression Regulation, Leukemic</topic><topic>Hematologic and hematopoietic diseases</topic><topic>HLA-A Antigens - biosynthesis</topic><topic>HLA-A Antigens - genetics</topic><topic>HLA-B Antigens - biosynthesis</topic><topic>HLA-B Antigens - genetics</topic><topic>Humans</topic><topic>Leukemia, Myeloid, Acute - genetics</topic><topic>Leukemia, Myeloid, Acute - immunology</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Medical sciences</topic><topic>Neoplasm Proteins - biosynthesis</topic><topic>Neoplasm Proteins - genetics</topic><topic>Neoplastic Stem Cells - immunology</topic><topic>Neoplastic Stem Cells - metabolism</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Neoplasm - genetics</topic><toplevel>online_resources</toplevel><creatorcontrib>D'ALFONSO, S</creatorcontrib><creatorcontrib>SAVOIA, P</creatorcontrib><creatorcontrib>PITTI, G</creatorcontrib><creatorcontrib>PERUCCIO, D</creatorcontrib><creatorcontrib>POZZI, C</creatorcontrib><creatorcontrib>CREPALDI, T</creatorcontrib><creatorcontrib>FALDA, M</creatorcontrib><creatorcontrib>FICARA, F</creatorcontrib><creatorcontrib>RESEGOTTI, L</creatorcontrib><creatorcontrib>MOMIGLIANO RICHIARDI, P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunogenetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>D'ALFONSO, S</au><au>SAVOIA, P</au><au>PITTI, G</au><au>PERUCCIO, D</au><au>POZZI, C</au><au>CREPALDI, T</au><au>FALDA, M</au><au>FICARA, F</au><au>RESEGOTTI, L</au><au>MOMIGLIANO RICHIARDI, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quantitative expression of HLA class I molecules in acute non-lymphoblastic leukaemia cells</atitle><jtitle>European journal of immunogenetics</jtitle><addtitle>Eur J Immunogenet</addtitle><date>1993-06</date><risdate>1993</risdate><volume>20</volume><issue>3</issue><spage>165</spage><epage>173</epage><pages>165-173</pages><issn>0960-7420</issn><eissn>1365-2370</eissn><abstract>The present study concerns a panel of 33 acute non lymphoblastic leukaemia (ANLL) patients, previously typed for HLA-A,B serological specificities and including samples with a normal HLA-A,B phenotype (3,4 detected specificities) as well as samples with missing and extra specificities. Samples were analysed at the protein and/or RNA level in order to verify whether the observed typing anomalies were due to a modified quantitative expression of class I molecules. The number of HLA-A,B assigned specificities correlated significantly with the cell surface class I expression detected by indirect immunofluorescence using the monomorphic anti-class I MoAb W6/32 (Spearman rank correlation test, P &lt; 0.01) and with the amount of class I Heavy Chain (HC, P &lt; 0.05) and beta-2-microglobulin (beta 2m, P &lt; 0.05) evaluated by Western blot in whole cell extracts. The RNA analysis suggested a HC-beta 2m coordinated down regulation at the mRNA level in a patient with no assigned HLA-A,B specificities. Another patient with no detectable HLA-A,B specificities showed a low expression selectively of the beta 2m protein. The results reported here demonstrate a heterogenous quantitative HLA class I expression in ANLL blasts, analogous to results reported for solid tumours.</abstract><cop>Oxford</cop><pub>Blackwell</pub><pmid>8338814</pmid><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-7420
ispartof European journal of immunogenetics, 1993-06, Vol.20 (3), p.165-173
issn 0960-7420
1365-2370
language eng
recordid cdi_proquest_miscellaneous_75858855
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Antigens, Neoplasm - biosynthesis
Antigens, Neoplasm - genetics
beta 2-Microglobulin - biosynthesis
beta 2-Microglobulin - genetics
Biological and medical sciences
Gene Expression Regulation, Leukemic
Hematologic and hematopoietic diseases
HLA-A Antigens - biosynthesis
HLA-A Antigens - genetics
HLA-B Antigens - biosynthesis
HLA-B Antigens - genetics
Humans
Leukemia, Myeloid, Acute - genetics
Leukemia, Myeloid, Acute - immunology
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Medical sciences
Neoplasm Proteins - biosynthesis
Neoplasm Proteins - genetics
Neoplastic Stem Cells - immunology
Neoplastic Stem Cells - metabolism
RNA, Messenger - genetics
RNA, Neoplasm - genetics
title Quantitative expression of HLA class I molecules in acute non-lymphoblastic leukaemia cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T21%3A58%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quantitative%20expression%20of%20HLA%20class%20I%20molecules%20in%20acute%20non-lymphoblastic%20leukaemia%20cells&rft.jtitle=European%20journal%20of%20immunogenetics&rft.au=D'ALFONSO,%20S&rft.date=1993-06&rft.volume=20&rft.issue=3&rft.spage=165&rft.epage=173&rft.pages=165-173&rft.issn=0960-7420&rft.eissn=1365-2370&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E75858855%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16699851&rft_id=info:pmid/8338814&rfr_iscdi=true